Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

1 results about "Acne scars" patented technology

A traditional Chinese medicine composition for improving acne

This invention discloses a traditional Chinese medicine composition for improving acne, consisting of Platycodon grandiflorus, Citronella rotundus, Taraxacum mongolicum, Angelica dahurica, Angelica sinensis, fermented soybean, Prunus persica, and Saffron. Studies have shown that anti-inflammatory Western medicines, heat-clearing and cooling traditional Chinese medicines, and topical anesthetic acne-removing drugs can constrict visceral capillaries or inhibit skin heat dissipation nerves, causing the body's heat to be unable to dissipate normally. This leads to increased heart rate and abnormally increased facial blood flow through hypothalamic regulation, compensating for heat loss and forming acne, while also increasing the burden on the heart. Long-term renal capillary constriction can also disrupt bone marrow hematopoietic homeostasis and increase the risk of leukemia. Platycodon grandiflorus, Citronella rotundus, Taraxacum mongolicum, Angelica sinensis, and Prunus persica can dilate visceral microvessels; Angelica dahurica bidirectionally regulates skin-visceral blood flow; fermented soybean stabilizes the body temperature center; and Saffron, within a safe dosage of 0.5-2 parts, bidirectionally regulates microvessels, achieving anti-inflammatory effects on the face, heat dissipation in the internal organs, and kidney protection and detoxification. This invention combines various drugs to dilate visceral blood vessels, stabilize central body temperature regulation, and suppress compensatory heart rate and facial congestion, thereby improving acne and acne scars from the root cause. It also protects the heart, kidneys, and blood system. The medicine is mild and can be taken for a long time. It is hormone-free, does not cause drug resistance, and is not prone to recurrence, making it suitable for industrial application.
Owner:YINGXUAN TRADITIONAL CHINESE MEDICINE TECHNOLOGY (HENGZHOU) CO LTD